What is Oruka Therapeutics, Inc. Common Stock's Market Cap?

Oruka Therapeutics, Inc. Common Stock's Market Cap is $6.2B, based on as-reported figures from SEC (XBRL) filings.

What is Oruka Therapeutics, Inc. Common Stock's Net Income (TTM)?

Oruka Therapeutics, Inc. Common Stock's Net Income (TTM) is -$132.9M, based on as-reported figures from SEC (XBRL) filings.

What is Oruka Therapeutics, Inc. Common Stock's EBITDA?

Oruka Therapeutics, Inc. Common Stock's EBITDA is -$154.9M, based on as-reported figures from SEC (XBRL) filings.

What is Oruka Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Oruka Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.01, based on as-reported figures from SEC (XBRL) filings.

Oruka Therapeutics, Inc. Common Stock (ORKA) Financial Statements

Oruka Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SB1GL2

XNAS · usd

94.31▲ 1.80 (1.95%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close92.51

Day's Range87.68 – 96.44

52-Week Range14.67 – 115.52

Volume867.8K

Avg Volume792.1K

Share Statistics

Shares Outstanding

Employees68

ExchangeXNAS

Listed2024-09-03

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Oruka Therapeutics, Inc. Common Stock (ORKA)

What is Oruka Therapeutics, Inc. Common Stock's Market Cap?: Oruka Therapeutics, Inc. Common Stock's Market Cap is $6.2B, based on as-reported figures from SEC (XBRL) filings.
What is Oruka Therapeutics, Inc. Common Stock's Net Income (TTM)?: Oruka Therapeutics, Inc. Common Stock's Net Income (TTM) is -$132.9M, based on as-reported figures from SEC (XBRL) filings.
What is Oruka Therapeutics, Inc. Common Stock's EBITDA?: Oruka Therapeutics, Inc. Common Stock's EBITDA is -$154.9M, based on as-reported figures from SEC (XBRL) filings.
What is Oruka Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Oruka Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.01, based on as-reported figures from SEC (XBRL) filings.